Continuous high-dose intravenous desferrioxamine treatment for iron overload
- PMID: 7263191
Continuous high-dose intravenous desferrioxamine treatment for iron overload
Abstract
We describe a patient with heavy posttransfusion iron overload, to whom continuous high-dose i.v. desferrioxamine was administered shortly before his death. The administration of nearly 500 g of this agent was followed by urinary excretion of 5.4 g of iron. The chelator therapy lost its efficiency in the last of five courses and the patient eventually died as a result of cardiac and hepatic damage related to iron overload. The theoretical and practical implications of these observations are discussed.